Tsuji K, Mizugaki H, Yokoo K, Kobayashi M, et al. Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: A real-world study (HOT2101). Cancer Sci 2024 Jan 29. doi: 10.1111/cas.16094.
PMID: 38287788